CYCLACILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Cyclacillin patents expire, and what generic alternatives are available?
Cyclacillin is a drug marketed by Teva and is included in one NDA.
The generic ingredient in CYCLACILLIN is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
Summary for CYCLACILLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 4,070 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CYCLACILLIN at DailyMed |
Medical Subject Heading (MeSH) Categories for CYCLACILLIN
US Patents and Regulatory Information for CYCLACILLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | CYCLACILLIN | cyclacillin | TABLET;ORAL | 062895-001 | Aug 4, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | CYCLACILLIN | cyclacillin | TABLET;ORAL | 062895-002 | Aug 4, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |